Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

September 04, 2020

In Re: MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 23, 2016

    Genentech Seeks Quick Win In Cancer Drug Dosage Case

    Roche's biotechnology subsidiary Genentech Inc. asked an Oklahoma federal judge Tuesday for a quick win in multidistrict litigation accusing the company of cheating hospitals by lying about the quantity of breast cancer medication Herceptin in each vial, saying the medical providers receive the federally approved amount of the drug.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login